Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 34 Carcinoma, Non-Small-Cell Lung 26 Breast Neoplasms 26 Lung Neoplasms 24 Colonic Neoplasms 18 Head and Neck Neoplasms 16 Rectal Neoplasms 14 Prostatic Neoplasms 11 Sarcoma 10 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Neoplasms 7 Mouth Neoplasms 7 Melanoma 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Ovarian Neoplasms 6 Glioblastoma 6 Precancerous Conditions 5 Neuroblastoma 5 Liver Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Carboplatin 4 spartalizumab 3 sintilimab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Celecoxib × Clear all

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡